Fas antigen and two tumor necrosis factor receptors (TNFR), p55 and p75, are implicated in the triggering of cell death upon stimulation by natural ligands and specific monoclonal antibodies. However, the relative efficiency of each receptor, the mechanisms that regulate their function and the signaling pathways they employ, remain to be elucidated. In this study, fusion proteins, composed of the extracellular domain of CD40 and the intracellular and transmembrane domains of Fas, TNFRp55 and TNFRp75, were stably expressed in a human melanoma cell line that is deficient in Fas and TNFR expression. Transfectants were stimulated by a soluble recombinant form of the CD40 ligand gp39, and the effect on cell viability determined. Engagement of all three fusion proteins by the gp39 ligand induced lethal signals, but the rate at which cell death occurred was distinct. Fas-derived signals were observed to have the most rapid effect, killing most cells within hours of stimulation, whereas TNFILp55-and TNFILp75-associated signals resulted in cell death within 2-3 d after engagement by ligand. It is interesting to note that optimal cell killing by all three fusion proteins was dependent on a critical, low to intermediate, cell surface expression level. High levels of fusion protein expression, on the other hand, were associated with inhibition of cell death. Our results provide a model to study Fas and TNFRmediated cell death and suggest a novel mechanism for the regulation of death signals triggered by members of the TNFR family.
M
echanisms that regulate cell death are essential for normal development and maintenance of homeostasis. Cell death can be developmentally controlled, by the expression of novel genes that induce the death signal at a specific stage of differentiation in response to defined physiologic stimuli (1) . The most common morphologic expression of such programmed cell death is apoptosis, characterized by cell shrinkage, zeiosis, or blebbing, of the plasma membrane, and nuclear collapse and fragmentation of the nuclear chromatin at interuucleosomal sites due to activation of an endogenous nuclease (1) (2) (3) (4) (5) . However, lethal cellular programs that lead to apoptosis may also be triggered by a variety of exogenous or environmental stimuli. Some of these are cell type specific, including glucocorticoid-dependent lymphocyte killing (6) , antigen receptor-associated thymocyte death (7, 8) and TGF-B-induced hepatocyte death, whereas others are effective on a broad range of cells, including target cell lysis by cytotoxic T cells (9) , radiation-induced DNA damage (10, 11) and engagement of specific cell surface receptors by natural ligands or antibodies (3, 4) . Recently, three structurally related cell surface receptors implicated in transduction of death signals in a broad range of cell types have been identified and characterized. They include the Fas antigen (12, 13) , and two distinct TNFR chains, p55 (14) (15) (16) and p75 (17, 18) . All three receptors belong to a family of cell surface glycoproteins that includes nerve growth factor receptor (19) , the T cell antigen CD27 (20) , the B cell receptor CD40 (21) , and the T cell-associated receptors CD30 (22) , and 4-1BB (23) .
TNFRs are broadly distributed in both normal and neoplastic cells and bind two related TNF molecules, TNF-ot and TNF-~ (24) . TNF-o~ is one of the principal mediators of inflammation, and interaction between TNF and TNFRs produces a range of effects depending on the nature of the target cell (24) . In certain tumor cells, engagement of TNFR by TNF induces death (24) (25) (26) (27) (28) . However, tumor cells and cell lines display variable sensitivity to TNF, some cell lines being readily lysed by low concentrations of TNF, whereas others appear to be TNF resistant even at high TNF concentrations. Several TNF-resistant tumor cell lines are killed by TNF in the presence of inhibitors of protein synthesis. The mechanisms responsible for sensitivity or resistance to TNF are largely unknown. Furthermore, the respective role of the two TNFR chains in triggering cell death is disputed, some studies suggesting that TNFRp55 is the principal mediator (27, 29) whereas others contend that p75 may be equally effective (28, 30) . Because several of the commonly used target cells constitutively express one or both TNFRs, it has been difficult to assess the effect of each receptor chain indepen-dently, and the possibility of direct or indirect cooperation between the two polypeptides has not been excluded.
The Fas antigen is a 43-kD cell surface glycoprotein that is constitutively expressed in a variety of normal tissues and tumor cell lines while being inducible in others (12, 13) . Administration of anti-Fas mAb in vitro (12) and in vivo (31) , triggers apoptosis of Fas-expressing cells, suggesting that Fas may play a critical role in the regulation of ceU death in a broad range of tissues. Mutations that inactivate Fas have been shown to be associated with the lymphoproliferative disorder of Ipr/Ipr mice (32) , and Fas has recently been implicated in cytotoxic T lymphocyte-mediated target cell death (33) .
Although Fas and TNFKs are currently grouped together as the principal cell death receptors, it is unclear whether they trigger the death signal along the same or distinct pathways, whether the potency of each receptor in any given cell is comparable, and whether their function is subject to similar or distinct regulatory circuits. To study the mechanisms that regulate Fas and TNFR-mediated cell death, we have developed fusion proteins composed of the extracdlular domain of the B cell-associated antigen CD40 and the transmembrane and intracellular domain of Fas, TNFRp55, and TNFKp75. CD40 was chosen to provide the extracellular domain of the fusion proteins because it is structurally related to TNFR and Fas but has no known cytotoxic function. On the contrary, stimulation of CD40 by a natural ligand, gp39, induces B cell activation and Ig dass switching (34) (35) (36) (37) . CD40-Fas and -TNFR fusion proteins were stably expressed in a human melanoma cell line that is deficient in Fas and TNFRs, and the transfectants tested for responses to stimulation by the CD40 ligand, gp39. Our results show that all three fusion proteins induce cell death upon engagement by the gp39 ligand. However, cellular response to the lethal signal cascade associated with each receptor is distinct, raising the possibility that Fas, TNFRp55, and TNFRp75 may operate via different pathways. Furthermore, the effidency of lethal signal delivery was observed to be dependent upon a critical level of cell surface receptor expression which may constitute a novel regulatory mechanism of Fas and TNFR function.
Materials and Methods
Development 0fCD40, Fas, TNFRp55, and TNFRp75 Fusion Proteins. A cDNA encoding Fas was amplified from a human PHA blast cDNA library by PCR using synthetic oligonucleotide primers based on the published sequence (12) . Primers complementary to the 5' and 3' extremities of the coding sequence were designed to contain an XhoI and a PstI endonuclease restriction site respectively, to facilitate insertion into the CDM8 vector. Fas cDNA was amplified by 30 cycles of PCR (94~ for 1 min; 60~ for 2 rain; 72~ for 3 min) using Amplitaq polymerase (Perkin Elmer, Norwalk, CT) and buffer conditions recommended by the vendor. The amplified sequence was subjected to XhoI and PstI endonuclease digestion and ligated to XhoI/PstI-cut CDM8 vector. The oligonucleotide primers were: Forward: 5'CGC GGG CTC GAG ATG CTG GGC ATC TGG ACC CTC CTA 3'; and Reverse: 5' CGC GGG CTG CAG CTA GAC CAA GCT TTG GAT TTC ATT 3'.
Development of the CD40-Fas chimera, was facilitated by the presence of the BamHI site in the membrane-proximal region of Fas (12 (18) . PCR conditions were identical to the ones above and 5' and 3' oligonucleotide primers were designed to contain BamHI and NotI sites, respectively. The primers were: p55 Forward: 5' CGC GGG GGA TCC ACA GTG CTG TTG CCC CTG GTC ATT TTC 3'; p55 Reverse: 5' CGA GGC GGC CGC TCA TCT GAG AAG ACT GGG CGC GGG 3'; p75 Foward: 5' CTC GCT GGA TCC GGC GAC TTC GCT CTT CCA GTT GGA CTG 3'; and p75 Reverse: 5' ACA GGC GGC CGC TTA ACT GGG CTT CAT CCC AGC ATC AGG 3'. To create CD40-TNFR chimeras, amplified TNFR sequences were subjected to BamHI and NotI digestion and ligated to the CD40-Fas vector, cut with B mHI/NotI to remove the transmembrane and cytoplasmic sequences of Fas.
Sequences encoding the extracellular domain of TNFRp55 were PCR amplified according to the conditions specified above. Oligonucleotide primers were designed to contain XhoI (5') and BamHI (3') restriction sites to allow inframe ligation with Fas transmembrahe and intraceUular-specific sequences. Oligonucleotide primers were: Forward: 5' CGC GGG CTC GAG ATG GGC CTC TCC ACC GTG CCT GAC CTG 3'; and Reverse: 5' CAC GGG GGA TCC GTC CTC AGT CGG CTT AAC ATT CTC 3'. The CD40 extracellular domain-specific sequences were excised from CD40-Fas with XhoI and BamFII and replaced by ligation of corresponding XhoI/BamHI-cut PCR-amplified TNFRp55 sequences, creating a TNFRp55-Fas chimera.
CD44 extracellular domain sequences were amplified using the following oligonudeotide primers: Forward: 5' CAC GGG CTC GAG ATG GAC AAG TTT TTG TTG CAC GCA 3'; and Reverse: 5' CAC GGG AGA TCT TTC TGG AAT TTG GGG TGT CCT TAT 3'. Amplified CD44 extracellular domain sequences were digested with XhoI and BglII and ligated to XhoI/BamHI-cut CD40-Fas vector, from which CD40-specific sequences had been excised.
Development of Stable Transfectants.
The human melanoma cell line MC has been described previously (38) . MC cells were detached from tissue culture plates with PBS containing 0.5 mM EDTA and resuspended in RPMI (Irvine Scientific, Santa Ana, CA) at a concentration of 107 ceUs/ml. CD40, CD40-Fas, CD40-TNFRp55, CD40-TNFRp75, and TNFRp55-Fas expression plasmids were added to 0.4 ml of cell suspension each along with the pSV2Neo selection vector at a ratio of 15:1/~g. Plasmids were introduced into the cells by electroporation, using a Gene Pulser (Bio-Rad Laboratories, Richmond, CA), at 625 V/cm, 960 gF. Cells were seeded onto culture plates in DMEM/20% fetal bovine serum (FBS) 1 (Irvine ,Scientific), and 48 h later, the medium was replaced by fresh DMEM/10% FBS supplemented with 1 mg/ml G418 (GIBCO BRL, Gaithersburg, MD). Resistant clones were detached and tested for CD40 and TNFR expression by indirect immunofluorescence.
Production of Sohble Recombinant CD40 Ligand. The development of a CD8-gp39 soluble fusion protein has been described previously (35) . The CDS-gp39 expression plasmid kindly provided by Sandro Aruffo (Bristol Myers-Squibb, Seattle, WA) was transfected into COS cells using DEAE-dextran/chloroquine. 12 h after transf~ction, the culture medium was removed and replaced by fresh serum-free DMEM. Cells were maintained in serum-free medium for 6-8 d, whereupon the medium was harvested. The concentration of CD8-gp39 was estimated at 0.5-1/~g/ml on Coomassiestained SDS gels.
mAbs and Immunofluorescenc~ Parental MC cells and transfectants were detached from culture plates with EDTA and incubated with 1-5/~g/ml anti-CD40 mAb $2C6 (39), anti-Fas mAb (Upstate Biotechnology, Inc., Lake Placid, NY), anti-TNFRp55 mAb htr-9 (18) or anti-TNFRp75 mAb utr-1 (18) Cytotoxicit? Assays. To determine the cytolytic effect of CD8-gp39 on MC transfectants, MC-C, MC40, MC40-Fas, MC40-p55, and MC40p75 were seeded in 96-well microtiter plates (Falcon Labware, Oxnard, CA) at 2 x 104 cells/well and cultured for 24 h in DMEM/10% FBS. Medium was then aspirated and replaced with CD8-gp39 COS cell supernatant or superuatant from mocktransfected cells. Cells were incubated with COS cell supernatants for various times, after which the supernatants were aspirated and cells incubated with 0.75% crystal violet (Sigma Chemical Co., St. Louis, MO) in a 50% ethanol, 0.25% NaC1, and 1.75% formaldehyde solution. Cells were then washed with water, air-dried, and dye eluted with PBS/1% SDS. Cell viability was reflected by dye absorbance determined by optical density measurement at 595 nm on an automated ELISA reader.
Results

Development of C D40-Fas, -TNFR p 55, and-TNFR p 75 Fusion Proteins.
A cDNA insert containing the coding sequence of Fas (12) was amplified by PCR from a human PHA blast cDNA library and inserted into the CDM8 expression vector. Sequences encoding the secretory signal peptide and extracdhlar domain of human CD40 (21) were amplified by PCR using synthetic oligonucleotide primers designed to contain endonudease restriction sites that facilitate inframe ligation to the Fas expression vector. The nudeotide sequence encoding the membrane proximal region of the extraceUular domain 1 Abbreviations used in this paper: FBS, fetal bovine serum; MFI, mean fluorescence intensity.
of human Fas contains a BamHI restriction site (12) that can be conveniently exploited for domain substitution. The CD40-Fas construct served as a cassette for subsequent switching of sequences encoding the transmembrane and intracellular regions. PCR-amplified transmembraue and intraceUular sequences of p55 and p75 TNFRs could thus be readily substituted for their FAS counterparts. The chimeric constructs are iUustrated in Fig. 1 .
Expression of CD40 and CD40-Fas, CIMO-TNFRp55, and CD40-TNFRp75 Fusion Proteins in a Human Melanoma. Wild-type CD40 cDNA and each of the chimeric constructs were introduced into COS cells by the DEAE-Dextran method and the cells tested for expression, 48 h later, of cell surface CD40 by indirect immunofluorescence, using the anti-CD40 mAb $2C6 (39) . Cells expressing all of the constructs showed appropriate reactivity with anti-CD40 mAb (data not shown). The human melanoma MC (38) was chosen for establishing stable transfectants because it shows no reactivity with antiFas, anti-TNFR, or anti-CD40 mAb (Fig. 2) , and is insensitive to anti-Fas mAb and TNF-oe (data not shown), cDNA cloues encoding wild-type CD40 and CD40 fusion proteins were cotransfected with the pSV2neo selection plasmid, at a ratio of 15:1, into MC cells by electroporation and the cells selected for neomycin resistance. Single neomycin-resistant clones were picked and tested for reactivity with antiCD40mAb. Several independent clones of each transfectant, expressing variable levels of the corresponding fusion protein (Fig. 3) were obtained, and selected for further study. Transfectants expressing wild-type CD40 (MC40) and selection vector only (MC-C) were used as controls. The panel of transfectants used throughout the study are listed in Table 1 .
Engagement of CD40 Fusion Proteins by CDS-gp39 Induces Lethal Signals in MC Transfectants.
To assess the functional properties of the fusion proteins, we used a soluble recombinant form of a cell surface CD40 ligand (35) . CD40 has recently been shown to interact with gp39, a type II integral membrane protein expressed on activated T cells (34, 35) . A recombinant soluble form of gp39, fused to the extracellular domain of CD8 has been developed and shown to retain its CD40-binding and stimulatory properties (35) . The CDS-gp39 fusion protein was observed to bind all transfectants expressing wild-type CD40 and CD40 fusion proteins (data not shown), and thus provided a suitable means to determine whether ligand-dependent engagement of CD40 might trigger activity of the intracellular Fas and TNFR domains. Representative MC40-Fas, MC40-p55, and MC40-p75 clones were incubated in microtiter wells with serum-free COS cell supernatants containing CDS-gp39, and observed by light microscopy for signs of cell death at multiple intervals over a 48-h period. MC40-Fas cells showed marked morphologic changes within 2 h of incubation, characterized by cell rounding, formation of surface blebs and chromatin condensation, corresponding to those associated with apoptosis ( Fig. 4 and data not shown) . MC40-p55 and MC40-p75 cells displayed similar morphologic changes but at a later time point, typically between 24 and 48 h after the start of incubation with CD8-gp39 supernatant. Apoptosis of MC40-Fas cells could be observed after pulsing the cells with CD8-gp39 for 15 min and replacing the supernatants with fresh, serum-free media, suggesting a high degree of sensitivity to Fas-associated death signals. MC40 transfectants, expressing wild-type CD40, were unaffected by CDS-gp39 superuatants as were MC-C and parental cells (data not shown), indicating that cell death was not due to the potential toxicity of the supernatants themselves. It is interesting to note that none of the transfectants were susceptible to anti-CD40 $2C6 mAb, which recognizes a CD40 epitope distinct from that bound by gp39 (Clement, M.-V., and I. Stamenkovic, unpublished results), even at high mAb concentrations (data not shown), nor did cross-linking of $2C6 by secondary antibodies have any effect.
The Efficiency of Fas-raediated Cytotoxicity Depends on a Critical Level of Receptor Expression.
To address the possible correlation between the level of fusion protein expression and the rapidity of cell death after triggering of CD40-Fas, eight independent MC40-Fas transfectant clones were tested for their
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Clement and Stamenkovic response to CD8-gp39. Clones were designated as low, intermediate, and high expressors according to their mean fluorescence intensity (MFI) as determined by flow cytometry using the anti-CD40 $2C6 mAb: clones with MFI <20 were designated as low, 20-150 as intermediate, and ~150 as high expressors (Table 1) . Cell death was assessed at several time points by measuring the incorporation of crystal violet as an indicator of cell viability. Four of the clones, MC40-Fas 5, 5bis, 10, and 13 were killed rapidly, with a half maximal response of <2 h. Maximal cell death occurred at 6 h after stimulation, with only 20-30% of cells remaining viable (Fig. 5) . Viability of these calls at 24 h remained at 15-25% (data not shown). The remaining four dones, MC40-Fas 4, 6, 14, and 19, displayed partial or near complete resistance to CD8-gp39 stimulation, with 60-95% viability at 6 h. At 24 h, however, viability of these clones fell to 40-70% (data not shown), consistent with reduced effectiveness of Fasmediated cytotoxidty. Remarkably, three of the four resistant clones, MC40-Fas 4, 6, and 14 were high expressors of CD40-Fas (Fig. 5 , and bility to cell death even at a 1:8 dilution of the CD8-gp39 supernatant (Fig. 6) expressors (according to the designation in Table 1 ) responded the least (Fig. 7 , and Table 1 ).
Inhibition of Protein Synthesis Enhances Ligand-mediated Cytotoxicity in MC40-Fas and MC40-p55 but not in MC40-p75
Transfectants. A clear distinction between MC40-p55 and MC40-p75 cell response to gp39 stimulation was observed in the presence of cydoheximide (Fig. 8) . Whereas susceptibility of MC40-p55 cells to gp39 was markedly increased by cydoheximide, resulting in maximal cell death within 24 h, MC40-p75 sensitivity was not altered (Fig. 8) . Similar to MC40-p55 cells, susceptibility of MC40-Fas transfectants to CD8-gp39 was enhanced by cydoheximide (Fig. 9) . The rate at which the most sensitive MC40-Fas clones were killed after triggering by CDS-gp39 (maximal cell death was observed at 6 h) was not significantly altered by addition of cydoheximide (data not shown), but the fraction of ceUs susceptible to Fas-induced cytotoxicity was increased (Fig. 9) . The potentiating effect of cydoheximide could be best demonstrated when MC40-Fas clones of different sensitivity were incubated with serial dilutions of CD8-gp39 supernatants in the presence or absence of the drug (Fig. 9) . Cydoheximide significantly reduced the threshold of sensitivity to ligandmediated Fas cytotoxicity in all transfectants tested (Fig. 9 , and data not shown). Furthermore, maximal cell death, even of partially resistant dones, was observed within 6 h in the presence of cydoheximide (data not shown).
TNFR-Fas and CD40-Fas Fusion Proteins Transduce Similar Cytotoxic Signals Whereas CD44-Fas Fails to Induce Cell
Death. To determine whether intracdlular and transmembrane Fas segments retain cytotoxic signaling properties when fused to the extracellular domain of other receptors, a TNFRp55-Fas chimera was designed and expressed in MC cells. Five stable transfectants were obtained. One of the transfectants expressed TNFRp55-Fas in the low range (MFI <20) and was resistant to TNF (Fig. 10) , reminiscent of low CD40-Fas expressor resistance to CD40 ligand (Fig. 5) . Each of the other four transfectants displayed inhomogeneous expression of the fusion protein covering low and intermediate levels with an MFI in the intermediate range of [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] . All four isolates were sensitive to TNF at a concentration of 6 ng/ml, with maximal cell death occurring within 6 h (Fig. 10) , similar to corresponding CD40-Fas transfectants exposed to CD8-gp39. Augmenting TNF concentration to 25 ng/ml failed to increase its cytotoxic effect (Fig. 10 ), but addition of cycloheximide augmented transfectant sensitivity to TNF, rendering as little as 0.6 ng/ml lethal (data not shown). However, only about 50% of cells from each of the transfectants were killed by TNF (Fig. 10) . This observation most likely reflects the broad range of TNFtLp55-Fas fusion protein expression in each isolate. Roughly 50% of cells expressed a low level of TNFRp55-Fas which, in the case of CD40-Fas transfectants and one TNFRp55-Fas-expressing done, was associated with resistance to ligand-induced, Fas-mediated cytotoxicity (Figs. 5 and 10) . To determine the phenotype of surviving cells after exposure to TNF, a representative low to intermediate level TNFRp55-Fas expressor was treated with 100 ng/ml TNF for 6 h, and the supernatant removed and replaced with fresh culture medium. After 24 h of culture, surviving cells were incubated with anti-TNFRp55 mAb htr-9 and subjected to FACS | analysis. The majority of the cells expressed low TNFRp55-Fas levels whereas most of the intermediate expressor population was depleted (Fig. 11) . Thus, intermediate and low TNFRp55-Fas and CD40-Fas expressors displayed similar susceptibility to ligand-induced cytotoxicity.
It is interesting to note that cells expressing a CD44-Fas fusion protein were resistant to anti-CD44 mAb triggering, as well as to stimulation by soluble and surface-bound hyaluronate, the principal CD44 ligand (40, 41) (data not shown). Resistance was not due to high or low fusion protein expression, as transfectants expressing a broad range of CD44-Fas levels were obtained and tested. 
Discussion
In the present work, we have developed an approach to fadlitate the study and comparison of Fas and TNFR-mediated cell death. Our strategy has relied on two critical factors: the choice of a human tumor cell line that does not respond to TNF-ot or anti-Fas mAb and that is deficient in Fas and TNFR expression, and the creation and expression of fusion proteins that bear a common extracellular domain that can be triggered by the same natural ligand. This combination has revealed that the three receptors have both common and distinct functional characteristics.
Engagement of receptors by specific ligands, or cross-linking by specific mAb, usually causes receptor dimerization or oligomerization which promotes recruitment of mediators that trigger a signaling cascade. It has been proposed that the extracellular domain of cell surface receptors may primarily serve to facilitate ligand-induced clustering of the cytoplasmic domain which is responsible for signal release (42) . Our results show that replacement of the extracellular domain of Fas and TNFRs by that of different molecules of the same receptor family does not abrogate transduction of lethal signals upon stimulation with corresponding ligands, indicating that expression of the extracellular domain of Fas and TNFRs is not required for triggering cell death. However, appropriate ligand-mediated clustering appears to be critical, as anti-CD40 mAb $2C6, which is costimulatory with inducers of B cell activation (39) , but recognizes an epitope distinct from that bound by gp39 (Clement, M.-V., and I. Stamenkovic, unpublished results), had no effect on the MC40-Fas and -TNFK transfectants even after extensive cross-linking by secondary antibody. Similarly, replacement of the extracellular domain of Pas by that of the hyaluronate receptor CD44 generated fusion proteins that could not induce cytotoxicity in MC cells after antibody or ligand-mediated cross-linking. The CD40 ligand, gp39, on the other hand, induced cytotoxic signals in all three transfectants, as did TNF-oe in MCTNFKp55-Fas cells. The TNF-ot molecule has been shown to possess three receptor binding sites, which induce the formation of TNFK trimers upon engagement (43) , and it has been suggested that gp39 may have a similar effect on the CD40 receptor (36) . These observations support the notion that the CD40, Fas, and TNF receptors may share similar oligomerization requirements for appropriate ligand-mediated signaling.
Stable transfectants expressing CD40-Fas, TNFKp55-Fas, and CD40-TNFK fusion proteins have helped demonstrate that the transmemhrane/intracellular domains of Fas, TNFK p55, and TNFKp75 can each mediate cell death independently. However, several distinctive functional properties have emerged. Whereas Fas-dependent signals induced cell death within hours of stimulus, in the most sensitive clones, detection of TNFR-dependent cytotoxicity required 2-3 d of exposure to ligand. The two CD40-TNFR fusion proteins displayed comparable cytotoxic signaling in MC cells, but TNFKp55-dependent cytotoxicity was enhanced by inhibitots of protein synthesis, whereas TNFl~p75-related signals were unaffected. The kinetics of Fas-dependent cytotoxicity was not significantly altered by cydoheximide in the most sensitive clones, suggesting that the observed death rate might reflect maximal efficiency of Fas-dependent cytotoxicity in these cells. However, the threshold of sensitivity to Fasmediated cell death in partially resistant clones was reduced by addition of cydoheximide. Thus, in MC melanoma cells, Fas and TNFKp55-associated cytotoxic signaling may be subject to the regulatory action of inhibitory intraceUular proteins whereas the cytolytic function of TNFRp75 appears to be independent of similar control mechanisms. Finally, our model suggests that the efficacy of Fas and TNFR cytotoxic signals may be dependent on a critical level of receptor surface expression. Intermediate levels of CD40-Fas and low levels of CD40-TNFK expression were associated with the most rapid and extensive killing in response to the CD40 ligand, whereas cells displaying high levels of fusion protein expression were partially resistant, and were rendered sensitive only in the presence of cycloheximide. Sensitivity of tumor cells to lethal signals from endogenous TNFRs and Fas is known to be highly variable (24, 44, 45) , consistent with the possibility that the activity of TNFK and Fas may be subject to cell type-specific regulation. The results presented here are consistent with the notion that the stoichiometry of the interaction between receptors, inhibitors of receptor function and second messengers that constitute the signaling cascade, may provide such a regulatory mechanism. Cell surface receptor signal transduction requires ligand-mediated receptor clustering that is thought to be necessary for any given signaling threshold to be reached. Optimal signal transduction presumably requires interaction between a critical fraction of receptors forming the ligand-mediated duster and specific second messenger molecules. Limitation of interactions between second messenger molecules and receptors by any number of possible mechanisms, including low steady state second messenger abundance, high turnover, or competitive binding by other molecules, would predict that receptor overexpression may result in receptor saturation of the messenger pool, and the presence of excess "free" receptors. Since ligand engagement of receptors is random, the fraction of receptors, within ligand-induced aggregates, which communicate with appropriate messengers would be reduced, and signaling efficiency potentially lowered. A simple explanation for ineffective cytotoxic signaling by transfectants expressing high levels of Fas and TNFK fusion proteins, might therefore be a receptor/messenger imbalance. Removal of inhibitor molecules by blockers of protein synthesis, on the other hand, may reduce the signaling threshold, and partially restore triggering of TNFKp55 and Fas-associated death signals despite suboptimal receptor-messenger interaction. Because receptor, second messenger, and receptor inhibitor stoichiometry is likely to vary among cell types, it is conceivable that efficient cytotoxicity might require high receptor expression in some cells and low expression in others. The model presented here may provide a means to help elucidate some of the mechanisms that regulate TNFR/Fas-mediated cell death.
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